FDA inspection
IDB Holland B.V.: FDA inspection ending Jan 12, 2022
FDA inspection 1204268 · No Action Indicated (NAI) · Baarle-Nassau
Key facts
| Inspection ID | 1204268 |
|---|---|
| Firm | IDB Holland B.V. |
| FEI number | 3010293768 |
| Address | Weverstraat 17 |
| City | Baarle-Nassau |
| Country | Netherlands |
| Fiscal year | 2022 |
| Inspection end date | Jan 12, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data